-
The 2024 International Symposium on Biomedicine...
Today, the biomedical industry is a key track in the global innovation race.From September 12 to 14, the symposium themed "Innovation, Integration, and Development" took place at the Shanghai Nanjiao Hotel. Co-sponsored by the Shanghai Biomedical Science and Technology I...Read more -
Epiprobe Biotech was invited to participate in ...
In the golden autumn of September, global attention once again turned to Fushan Bay, where the All-China Women's Federation, the SCO Cooperation Committee, the Shandong Provincial Government, and the SCO Secretariat co-hosted this significant event. The forum took place ...Read more -
Over 60,000 cases were registered for participa...
Over 60,000 cases were registered for participation! Epiprobe Biotech 100,000-case large-scale public welfare scientific research project for the prevention of cervical cancer has entered the follow-up stage ...Read more -
Congratulations! Epiprobe Biotech Wins Two R...
Recently, the 3rd ZAODX World Cancer Early Detection Conference was successfully held at the Xiongan Exhibition Center in Xiongan New Area, Hebei Province. This year's conference, with the theme of "Early Detection of Cancer, Standardized Action," covered multiple discip...Read more -
The outpost against cancer: universal cancer on...
MINI REVIEW The outpost against cancer: universal cancer only markers Chengchen Qian1, Xiaolong Zou2, Wei Li1,3, Yinshan Li4, Wenqiang Yu5 1Shanghai Epiprobe Biotechnology Co., Ltd, Shanghai 200233, China; 2 Department of General Surgery, the First Affiliated Hospital of...Read more -
Epiprobe Biotech’s early detection produc...
On April 20, 2024, The Expert Consensus on Detection and Clinical Application of Tumor DNA Methylation Markers (hereinafter referred to as "Consensus"), which was condensed by the Expert Committee of Tumor Markers Professional Comm...Read more -
Epiprobe Biotech crack the problem of cervical ...
Cervical cancer is a cancer that has plagued women for a long time, with more than 500,000 new cervical cancers worldwide every year and more than 300,000 deaths per year. The prevention and treatment situation of cervical cancer in China is grim, and the incidence of ce...Read more -
Methylation DNA Detection Kits for Endometrial ...
Endometrial cancer is a prevalent gynecological malignancy, and its early detection is crucial for successful treatment. Methylation DNA detection kits have emerged as a promising tool for the early diagnosis of endometrial cancer. These kits are designed to detect speci...Read more -
CCTV network report: Epiprobe Biotech 100,000 c...
Eliminate cervical cancer, Yi spectrum in action. CCTV network on March 6 published a news video of the launch of a large-scale public welfare project to prevent cervical cancer in Shandong Province "Eliminating cervical ...Read more -
Fudan University Research Team Targets Another ...
On July 6, 2022, the research team led by Dr. Yu Wenqiang at the Research Institute of Fudan University affiliated with the Fudan University Shanghai Cancer Center, in collaboration with the team at the Airforce Medical University's Xijing Hospital, identified the third ...Read more -
Epiprobe company won the title of “Specia...
Recently, Shanghai Municipal Commission of Economy and Information Technology announced the list of Shanghai small and medium-sized enterprises which are specialization, refinement, distinctiveness and novelty (second batch) in 2022. Shanghai Epiprobe Biotechnology Co., Ltd. relies on its experti...Read more -
The Urothelial Cancer Detection Kit was recogni...
Early May 2023, TAGMe DNA Methylation Detection Kit(qPCR) for Urothelial Cancer independently developed by Shanghai Epiprobe Biotechnology Co., Ltd, obtained “Breakthrough Device Designation” from US FDA. US FDA Breakthrough Devices Program aims to ensure promoting the a...Read more
